DOCSLIB.ORG

XI. COMPLICATIONS of PREGNANCY, Childbffith and the PUERPERIUM 630 Hydatidiform Mole Trophoblastic Disease NOS Vesicular Mole Ex

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
XI. COMPLICATIONS of PREGNANCY, Childbffith and the PUERPERIUM 630 Hydatidiform Mole Trophoblastic Disease NOS Vesicular Mole Ex XI. COMPLICATIONS OF PREGNANCY, CHILDBffiTH AND THE PUERPERIUM PREGNANCY WITH ABORTIVE OUTCOME (630-639) 630 Hydatidiform mole Trophoblastic disease NOS Vesicular mole Excludes: chorionepithelioma (181) 631 Other abnormal product of conception Blighted ovum Mole: NOS carneous fleshy Excludes: with mention of conditions in 630 (630) 632 Missed abortion Early fetal death with retention of dead fetus Retained products of conception, not following spontaneous or induced abortion or delivery Excludes: failed induced abortion (638) missed delivery (656.4) with abnormal product of conception (630, 631) 633 Ectopic pregnancy Includes: ruptured ectopic pregnancy 633.0 Abdominal pregnancy 633.1 Tubalpregnancy Fallopian pregnancy Rupture of (fallopian) tube due to pregnancy Tubal abortion 633.2 Ovarian pregnancy 633.8 Other ectopic pregnancy Pregnancy: Pregnancy: cervical intraligamentous combined mesometric cornual mural - 355- 356 TABULAR LIST 633.9 Unspecified The following fourth-digit subdivisions are for use with categories 634-638: .0 Complicated by genital tract and pelvic infection [any condition listed in 639.0] .1 Complicated by delayed or excessive haemorrhage [any condition listed in 639.1] .2 Complicated by damage to pelvic organs and tissues [any condi- tion listed in 639.2] .3 Complicated by renal failure [any condition listed in 639.3] .4 Complicated by metabolic disorder [any condition listed in 639.4] .5 Complicated by shock [any condition listed in 639.5] .6 Complicated by embolism [any condition listed in 639.6] .7 With other specified complications [any condition listed in 639.8] .8 With unspecified complications .9 Without mention of complication 634 Spontaneous abortion [See above for fourth-digit subdivisions] Includes: spontaneous abortion (complete) (incomplete) 635 Legally induced abortion [See above for fourth-digit subdivisions] Includes: abortion: legal therapeutic termination of pregnancy: legal therapeutic Excludes: menstrual extraction or regulation (V25.3) 636 ruegally induced abortion [See above for fourth-digit subdivisions] Includes: abortion (complete) (incomplete): criminal illegal 637 Unspecified abortion [See above for fourth-digit subdivisions] Includes: abortion (complete) (incomplete) NOS retained products of conception following abortion, not classifiable elsewhere PREGNANCY, CHILDBIRTH, PUERPERIUM 357 638 Failed attempted' abortion [See page 356 for fourth-digit subdivisions] Includes: failure of attempted induction of (legal) abortion Excludes: incomplete abortion (634-637) 639 Complications following abortion and ectopic and molar pregnancies Note: This category is provided for use when it is required to classify separately the complications listed at fourth-digit level in cate­ gories 634-638; for example: a) when the complication itself was responsible for an episode of medical care, the abortion, ectopic or molar pregnancy itself having been dealt with at a previous episode b) when these conditions are immediate complications of ectopic or molar pregnancies classifiable to 630-633 where they cannot be identified at fourth-digit level. 639,0 Genital tract and pelvic infection Endometritis Parametritis Pelvic peritonitis Salpingitis following conditions classifiable to 630-638 Salpingo-oophoritis Sepsis NOS Septicaemia NOS Excludes: urinary tract infection (639,8) 639,1 Delayed or excessive haemorrhage Afibrinogenaemia" d ) 10C' 11' owmg con d't'lIOns D efib nnatIOn syn rom~ classifiable to 630-638 Intravascular haemolysls 639,2 Damage to pelvic organs and tissues Laceration, perforation or tear of: bladder bowel following conditions broad ligament classifiable to 630-638 cervix periurethral tissue uterus 639.3 Renal failure Oliguria Renal: failure (acute) following conditions classifiable to 630-638 shutdown tubular necrosis Uraemia 358 TABULAR LIST 639.4 Metabolic disorders Electrolyte imbalance following conditions classifiable to 630-638 639.5 Shock Circulatory collapse } following conditions Shock (postoperative) (septic) classifiable to 630-638 639.6 Embolism Embolism: NOS aIr amniotic fluid 1 blood-clot following conditions classifiable to 630-638 pulmonary I pyaemic septic soap 639.8 Other specified complications Cardiac arrest or failure } . · followmg condItions classIfiable to 630-638 Cere b raI anOXia 639.9 Unspecified complications following conditions classifiable to 630-638 COMPLICATIONS MAINLY RELATED TO PREGNANCY (640-648) Includes: the listed conditions even if they arose or were present during labour, delivery or the puerperium 640 Haemorrhage in early pregnancy Includes: haemorrhage before completion of 22 weeks' gestation 640.0 Threatened abortion 640.8 Other 640.9 Unspecified 641 Antepartum haemorrhage, abruptio placentae, and placenta praevia 641.0 Placenta praevia without· haemorrhage Low implantation of placenta without haemorrhage Placenta praevia noted: during pregnancy before labour and delivered by caesarean section, without mention of haemorrhage PREGNANCY, CHILDBIRTH, PUERPERIUM 359 641.1 Haemorrhage from placenta praevia Low-lying placenta Placenta praevia: l marginal NOS or with haemorrhage (intrapartum) partial total Excludes: haemorrhage from vasa praevia (663.5) 641.2 Premature separation of placenta Ablatio placentae Accidental antepartum haemor- Abruptio placentae rhage Premature separation of normally implanted placenta 641.3 Antepartum haemorrhage associated with coagulation defects Antepartum or intrapartum haemorrhage associated with: afibrinogenaemia hypofibrinogenaemia hyperfibrinolysis 641.8 Other antepartum haemorrhage Antepartum or intrapartum haemorrhage associated with: trauma uterine leiomyoma 641.9 Unspecified antepartum haerrorrhage Haemorrhage: antepartum NOS intrapartum NOS of pregnancy NOS 642 Hypertension complicating pregnancy, childbirth and the puer­ perium 642.0 Benign essential hypertension complicating pregnancy, childbirth and the puerperium Hypertension: benign essential lspecified as complicating, or as a reason for chronic NOS obstetric care during, pregnancy, childbirth essential or the puerperium pre-existing NOS 642.1 Hypertension secondary to renal disease, complicating pregnancy, childbirth and the puerperiur1rz ! Hypertension secondary to renal disease, specified as complicating, or as a reason for obstetric care during, pregnancy, childbirth or the puerperium 360 TABULAR LIST 642.2 Other pre-existing hypertension complicating pregnancy, childbirth and the puerperium Malignant hypertension } Hypertensive: specified as complicating, or as a reason for heart disease obstetric care during, pregnancy, child- heart and renal disease birth or the puerperium renal disease 642.3 Transient hypertension of pregnancy Transient hypertension, so described, in pregnancy, childbirth or the puerperium 642.4 Mild or unspecified pre-eclampsia Hypertension in pregnancy, childbirth or the puerperium,· not· specified as pre-existing, with either albuminuria or oedema, or both; mild or unspecified Pre-eclampsia: Toxaemia (pre-eclamptic): NOS NOS mild mild Excludes: albuminuria in pregnancy, without mention of hypertension (646.2) oedema in pregnancy, without mention of hypertension (646.1) 642.5 Severe pre-eclampsia Hypertension in pregnancy, childbirth or the puerperium, not specified as pre-existing, with either albuminuria or oedema, or both; spec­ ified as severe Pre-eclampsia, severe Toxaemia (pre-eclamptic), severe 642.6 Eclampsia Toxaemia: eclamptic with convulsions 642.7 Pre-eclampsia or eclampsia superimposed on pre-existing hyper­ tension Conditions in 642.4-642.6, with conditions in 642.0-642.2 642.9 Unspecified hypertention complicating pregnancy, childbirth and the puerperium Hypertension NOS, without mention of albuminuria or oedema, com­ plicating pregnancy, childbirth or the puerperium 643 Excessive vomiting in pregnancy PREGNANCY, CHILDBIRTH, PUERPERIUM 361 643.0 Mild hyperemesis gravidarum Hyperemesis gravidarum, mild or unspecified, starting before the end of the 22nd week 643.1 Hyperemesis gravidarum with metabolic disturbance Hyperemesis gravidarum, starting before the end of the 22nd week, with metabolic disturbance such as: carbohydrate depletion dehydration electrolyte imbalance 643.2 Late vomiting of pregnancy Excessive vomiting starting after 22 completed weeks of gestation 643.8 Other vomiting complicating pregnancy Vomiting due to organic disease or other cause, specified as complicating pregnancy, or as a reason for obstetric care during pregnancy Use additional code, if desired, to identify cause 643.9 Unspecified vomiting of pregnancy Vomiting as a reason for care during pregnancy, length of gestation unspecified 644 Early or threatened labour 644.0 Threatened labour False labour 644.1 Early onset of delivery Onset (spontaneous) of delivery before 37 weeks gestation 645 Prolonged pregnancy Post-dates Post-term 646 Other complications of pregnancy, not elsewhere classified 646.0 Papyraceous fetus 646.1 Oedema or excessive weight gain in pregnancy, without mention of hypertension Gestational oedema Excludes: with mention of hypertension (642.-) 646.2 Unspecified renal disease in pregnancy, without mention of hyper- tension Albuminuria ) Nephropathy NOS in pregnancy, without mention of hypertension Renal disease NOS Gestational proteinuria Excludes: with mention of hypertension (642.-) 362 TABULAR LIST 646.3 Habitual aborter Excludes: with current abortion (634.-) without current pregnancy (629.9) 646.4 Peripheral neuritis in pregnancy 646.5 Asymptomatic bacteriuria in pregnancy 646.6 Infections of genitourinary
Load more

Recommended publications
  • Impetigo Herpetiformis: a Case Report
    Perinatal Journal • Vol: 13, Issue: 4/December 2005 227 Impetigo Herpetiformis: A Case Report ‹ncim Bezircio¤lu1, Merve Biçer1, Levent Karc›1, Füsun Özder2, Ali Balo¤lu1 1First Clinic of Gynecology and Obstetrics, 2Clinics of Dermatology, Atatürk Training and Research Hospital, ‹zmir Abstract Objective: Impetigo herpetiformis is a rare and potentially life-threatening pustular dermatosis affecting mainly pregnant women. We report here a case of impetigo herpetiformis which occured in twenty-ninth week of pregnancy. Case: A 32 year old gravida 2, para1 pregnant woman who was referred to our institution because of congestive heart failure, gestational diabetes mellitus and oligohidroamnios in 27th gestational age was hospitalized. Eruptive pustular lesions which appeared in 29th week of the gestation has spread her entire body. Her pustular cultures were negative. A punch skin biopsy from a pustule on the trunk made the diagnosis of impetigo herpetiformis. The patient who developed spontaneous uterine contractions was treated with betamethazone and tocolysis. The patient who did not respond to this treatment was taken to delivery at 30 weeks of gestation.The newborn showed no skin lesions after birth. The skin lesions of the mother improved in the second postpartum week. Conclusion: The rates of maternal mortality and fetal mortality and morbidity due to placental insufficiency are increased in impetigo herpetiformis. To reduce the mortality and morbidity rates the antenatal management of impetigo herpetiformis should be organized with a multidisciplinary approach. Keywords: Impetigo herpetiformis, generalized pustular psoriasis. Impetigo herpetiformis: Bir olgu sunumu Amaç: ‹mpetigo herpetiformis gebelerde görülen yaflam› riske edebilen nadir bir püstüler dermatozdur. Bu çal›flmada 29.gebe- lik haftas›nda ortaya ç›kan impetigo herpetiformis olgusu sunulmufltur.
    [Show full text]
  • The Combined Effect of Sulfanilamide and Penicillin in Treatment Of
    THE COMBINED EFFECT OF STJLFANILAMIDE AND PENICILLIN IN TREATMENT OF EXPERIMENTAL ERYSIPELOTHRIX RHUSIOPATHIAE INFECTION OF MICE* JOSEPH V. KLAUDER, M.D. AND ANNA M. RULE In a previous communication (1) we reported the results of determinations oi the therapeutic effect of sulfonamide compounds in mice inoculated with Er- ysipelothrix rhusiopathiae. A report was also made of the ineffective use of these compounds in treatment of patients with erysipeloid of Rosenbach and in treatment of one patient with the septicemic form of the infection (2). In our experimental study sulfanilamide, sulfapyridine, sulfathiazole and sul- fadiazine were separately administered to mice orally in doses of 0.2 Gm. per kilogram of body weight. To some the compounds were administered twice daily for two days before inoculation with a virulent strain of Erysipelothrix rhu- siopathiae and twice daily thereafter for six additional days. For others treat- ment was begun four hours after inoculation and then administered twice daily for six additional days; in still others, for eight additional days. It was observed that 12.5 per cent of mice treated before or after the admin- istration of these compounds survived. Additional evidence of some therapeutic effect was the greater percentage (50 per cent) of survival of the animals treated before inoculation and the longer time of survival of animals treated after inocu- lation compared with those of the untreated control group. The therapeutic effect of these compounds is therefore limited. Sulfanilamide and sulfapyridine appeared to give better results than sulfathiazole and sulfadiazine. The thera- peutic effect of these compounds was slightly enhanced when they were employed in conjunction with subcurative injections of immune serum.
    [Show full text]
  • PLAGIOCEPHALY and CRANIOSYNOSTOSIS TREATMENT Policy Number: ORT010 Effective Date: February 1, 2019
    UnitedHealthcare® Commercial Medical Policy PLAGIOCEPHALY AND CRANIOSYNOSTOSIS TREATMENT Policy Number: ORT010 Effective Date: February 1, 2019 Table of Contents Page COVERAGE RATIONALE ............................................. 1 CENTERS FOR MEDICARE AND MEDICAID SERVICES DEFINITIONS .......................................................... 1 (CMS) .................................................................... 6 APPLICABLE CODES ................................................. 2 REFERENCES .......................................................... 6 DESCRIPTION OF SERVICES ...................................... 2 POLICY HISTORY/REVISION INFORMATION ................. 7 CLINICAL EVIDENCE ................................................ 4 INSTRUCTIONS FOR USE .......................................... 7 U.S. FOOD AND DRUG ADMINISTRATION (FDA) ........... 6 COVERAGE RATIONALE The following are proven and medically necessary: Cranial orthotic devices for treating infants with the following conditions: o Craniofacial asymmetry with severe (non-synostotic) positional plagiocephaly when ALL of the following criteria are met: . Infant is between 3-18 months of age . Severe plagiocephaly is present with or without torticollis . Documentation of a trial of conservative therapy of at least 2 months duration with cranial repositioning, with or without stretching therapy o Craniosynostosis (i.e., synostotic plagiocephaly) following surgical correction Cranial orthotic devices used for treating infants with mild to moderate plagiocephaly
    [Show full text]
  • The Value of Diver Knowledge for Manta Ray Conservation in the Maldives
    The Value of Diver Knowledge for Manta Ray Conservation in the Maldives Environment Department MSc Marine Environmental Management Summer Placement Project www.mantatrust.org 1 Table of Contents Abstract ....................................................................................................................................................................................3 Introduction .............................................................................................................................................................................3 Methods .....................................................................................................................................................................................5 Results ........................................................................................................................................................................................7 Manta ray sightings and seasonal patterns .............................................................................................................7 Manta ray hotspots ........................................................................................................................................................7 Changes in manta ray abundance .............................................................................................................................8 Abundance of other marine species .........................................................................................................................9
    [Show full text]
  • FROGLOG Newsletter of the Declining Amphibian Populations Task Force
    Salamandra salamandra by Franco Andreone ISSN 1026-0269 FROGLOG Newsletter of the Declining Amphibian Populations Task Force August 2004, Number 64. Meteyer et al. (2000) and Ouellet very low number of abnormalities. We (2000). only found one L. kuhlii, which may We examined a total of 4,331 have strayed from a nearby stream. frogs of 23 species and found 20 A third of abnormalities were types of deformities in 9 species of due to trauma; these included digit frogs. We divided deformities into two amputations (16% of all general types: developmental abnormalities), limb amputations (2%), abnormalities and trauma (injuries). fractured limbs (7%) and skin wounds Morphological Abnormalities in We distinguished trauma (4%). The most common Frogs of West Java, Indonesia abnormalities based on the developmental abnormalities were appearance of old scars or, if they digital (43%) and, of these, By Mirza D. Kusrini, Ross A. Alford, involved digits, the occurrence of brachydactyly (16.3%), syndactyly Anisa Fitri, Dede M. Nasir, Sumantri digital re-growth. Developmental (14.6%) and ectrodactyly (11.4%) Rahardyansah abnormalities occurred in limbs were the three most common. In recent decades, amphibian (amelia, micromelia, brachymelia, The oldest specimen of F. deformities have generated public hemimelia, ectromelia, taumelia, cuta- limnocharis stored in the MZB that interest as high incidences have been neous fusions), digits (ectrodactyly, exhibited abnormalities was a juvenile found in several locations, notably in brachydactyly, syndactyly, polydactyly, frog captured on 16 November 1921 North America (Helgen et al., 1998; clinodactyly), the back-bone (scoli- from Bogor without one leg (amelia) Ouellet, 2000). The only report on the osis), the eyes (anophthalmy) and the (ID057.10).
    [Show full text]
  • Olivar C Castejon S. the Histomorphology of Tiny Lobes from the Bilobed Placenta
    Cell & Cellular Life Sciences Journal MEDWIN PUBLISHERS ISSN: 2578-4811 Committed to Create Value for researchers The Histomorphology of Tiny Lobes from the Bilobed Placenta Olivar C Castejon S* Research Article Faculty of Health Sciences, University of Carabobo, Venezuela Volume 5 Issue 1 Received Date: January 24, 2020 *Corresponding author: Olivar C Castejon Moc, Faculty of Health Sciences, Laboratory of Published Date: February 14, 2020 Electron Microscopy, Center for Research and Teaching Analysis of the Aragua Nucleus, CIADANA, DOI: 10.23880/cclsj-16000149 Aragua State, Maracay, Venezuela, Email: [email protected] Abstract Two bilobed placentas were obtained of woman pregnancy at 37 and 38 weeks of gestation with newborns live and examined the villous tree with light microscope. Two small lobes were found in one placenta and other in the second placenta. Two normal placentas were taken as control. Ten histological samples by each lobe were processed with H&E stain. Five biopsies by each normal placenta were taken and three histological slides by biopsy were dyed equally. Degenerative changes at level of vessels of the placental villi were noted in stem villi: stromal lysis, multiple capillarity, congestioned vessels, and increased villi, in immature villi the vessels are near to the syncytium indicating extensive hypoxic villous damage. In this condition a dilatation of vessels. Regions of immature villi, pre- infarcts, deficiency of terminal villi in mature intermediate villi, destroyed diminution of the blood flow or events of thrombosis could to be affecting the growth of these small lobules. Keywords: Tiny Placental Lobes; Degenerative Changes; Bipartite Placenta Abbreviations: VEGF: Vascular Endothelial Growth The origen of the bilobed placenta is unknown.
    [Show full text]
  • WO 2014/134709 Al 12 September 2014 (12.09.2014) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2014/134709 Al 12 September 2014 (12.09.2014) P O P C T (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every A61K 31/05 (2006.01) A61P 31/02 (2006.01) kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, (21) International Application Number: BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, PCT/CA20 14/000 174 DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, (22) International Filing Date: HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, 4 March 2014 (04.03.2014) KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, (25) Filing Language: English OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, (26) Publication Language: English SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, (30) Priority Data: ZW. 13/790,91 1 8 March 2013 (08.03.2013) US (84) Designated States (unless otherwise indicated, for every (71) Applicant: LABORATOIRE M2 [CA/CA]; 4005-A, rue kind of regional protection available): ARIPO (BW, GH, de la Garlock, Sherbrooke, Quebec J1L 1W9 (CA). GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, (72) Inventors: LEMIRE, Gaetan; 6505, rue de la fougere, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, Sherbrooke, Quebec JIN 3W3 (CA).
    [Show full text]
  • Differential Diagnosis of Oromandibular Limb Hypogenesis Syndromes Ole Junga,B, Ralf Smeetsb, Henning Hankenb, Reinhard E
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2016 Jun; 160(2):310-315. A patient with Charlie M Syndrome: Differential diagnosis of Oromandibular Limb Hypogenesis Syndromes Ole Junga,b, Ralf Smeetsb, Henning Hankenb, Reinhard E. Friedrichb, Max Heilandb, Amir Tagnihaa, Brian Labowa Aim. In order to provide adequate treatment to a patient with a subtype of Oromandibular Limb Hypogenesis Syndromes (OLHS), this study aimed to review and to analyze the current literature and treatment options of OLHS. Methods. Literature review in PubMed and Sciencedirect. Due to the small number of results, all available references were analyzed precisely. Results. Cases of OLHS are formerly rare and often incomplete. There are various classifications available, which, however, often seem confusing and are of little practical relevance. Furthermore, we present a complete case report of a patient with Charlie M syndrome, a type IV (Chicarilli)/ V (Hall) OLHS malformation. We also describe embryologic pathogenesis and differential diagnoses. Conclusion. As a result of our literature review, we recommend an adjusted classification for OLHS. Key words: Oromandibular Limb Hypogenesis Syndromes (OLHS), Charlie M Syndrome, Oromandibular and limb hypogenesis malformations (OLHM) Received: August 1, 2015; Accepted with revision: April 8, 2016; Available online: April 27, 2016 http://dx.doi.org/10.5507/bp.2016.020 aDepartment of Plastic and Oral Surgery, Children´s Hospital Boston, Harvard Medical School, Boston, USA bDepartment of Oral and Maxillofacial Surgery, University Medical Center Hamburg, Hamburg, Germany Corresponding author: Ole Jung, e-mail: [email protected] INTRODUCTION CASE REPORT Oromandibular Limb Hypogenesis Syndromes A twenty-three-year-old male with severe oroman- (OLHS) describe a group of heterogeneous malforma- dibular and limb deformities presented for mandibular tions of the face and body.
    [Show full text]
  • N35.12 Postinfective Urethral Stricture, NEC, Female N35.811 Other
    N35.12 Postinfective urethral stricture, NEC, female N35.811 Other urethral stricture, male, meatal N35.812 Other urethral bulbous stricture, male N35.813 Other membranous urethral stricture, male N35.814 Other anterior urethral stricture, male, anterior N35.816 Other urethral stricture, male, overlapping sites N35.819 Other urethral stricture, male, unspecified site N35.82 Other urethral stricture, female N35.911 Unspecified urethral stricture, male, meatal N35.912 Unspecified bulbous urethral stricture, male N35.913 Unspecified membranous urethral stricture, male N35.914 Unspecified anterior urethral stricture, male N35.916 Unspecified urethral stricture, male, overlapping sites N35.919 Unspecified urethral stricture, male, unspecified site N35.92 Unspecified urethral stricture, female N36.0 Urethral fistula N36.1 Urethral diverticulum N36.2 Urethral caruncle N36.41 Hypermobility of urethra N36.42 Intrinsic sphincter deficiency (ISD) N36.43 Combined hypermobility of urethra and intrns sphincter defic N36.44 Muscular disorders of urethra N36.5 Urethral false passage N36.8 Other specified disorders of urethra N36.9 Urethral disorder, unspecified N37 Urethral disorders in diseases classified elsewhere N39.0 Urinary tract infection, site not specified N39.3 Stress incontinence (female) (male) N39.41 Urge incontinence N39.42 Incontinence without sensory awareness N39.43 Post-void dribbling N39.44 Nocturnal enuresis N39.45 Continuous leakage N39.46 Mixed incontinence N39.490 Overflow incontinence N39.491 Coital incontinence N39.492 Postural
    [Show full text]
  • Full-Term Abdominal Extrauterine Pregnancy
    Masukume et al. Journal of Medical Case Reports 2013, 7:10 JOURNAL OF MEDICAL http://www.jmedicalcasereports.com/content/7/1/10 CASE REPORTS CASE REPORT Open Access Full-term abdominal extrauterine pregnancy complicated by post-operative ascites with successful outcome: a case report Gwinyai Masukume1*, Elton Sengurayi1, Alfred Muchara1, Emmanuel Mucheni2, Wedu Ndebele3 and Solwayo Ngwenya1 Abstract Introduction: Advanced abdominal (extrauterine) pregnancy is a rare condition with high maternal and fetal morbidity and mortality. Because the placentation in advanced abdominal pregnancy is presumed to be inadequate, advanced abdominal pregnancy can be complicated by pre-eclampsia, which is another condition with high maternal and perinatal morbidity and mortality. Diagnosis and management of advanced abdominal pregnancy is difficult. Case presentation: We present the case of a 33-year-old African woman in her first pregnancy who had a full-term advanced abdominal pregnancy and developed gross ascites post-operatively. The patient was successfully managed; both the patient and her baby are apparently doing well. Conclusion: Because most diagnoses of advanced abdominal pregnancy are missed pre-operatively, even with the use of sonography, the cornerstones of successful management seem to be quick intra-operative recognition, surgical skill, ready access to blood products, meticulous post-operative care and thorough assessment of the newborn. Introduction Ovarian, tubal and intraligamentary pregnancies are Advanced abdominal (extrauterine) pregnancy (AAP) is excluded from the definition of AAP. defined as a fetus living or showing signs of having once Maternal and fetal morbidity and mortality are high lived and developed in the mother’s abdominal cavity with AAP [1-5].
    [Show full text]
  • PHARMACEUTICAL APPENDIX to the TARIFF SCHEDULE 2 Table 1
    Harmonized Tariff Schedule of the United States (2020) Revision 19 Annotated for Statistical Reporting Purposes PHARMACEUTICAL APPENDIX TO THE HARMONIZED TARIFF SCHEDULE Harmonized Tariff Schedule of the United States (2020) Revision 19 Annotated for Statistical Reporting Purposes PHARMACEUTICAL APPENDIX TO THE TARIFF SCHEDULE 2 Table 1. This table enumerates products described by International Non-proprietary Names INN which shall be entered free of duty under general note 13 to the tariff schedule. The Chemical Abstracts Service CAS registry numbers also set forth in this table are included to assist in the identification of the products concerned. For purposes of the tariff schedule, any references to a product enumerated in this table includes such product by whatever name known.
    [Show full text]
  • A Guide to Obstetrical Coding Production of This Document Is Made Possible by Financial Contributions from Health Canada and Provincial and Territorial Governments
    ICD-10-CA | CCI A Guide to Obstetrical Coding Production of this document is made possible by financial contributions from Health Canada and provincial and territorial governments. The views expressed herein do not necessarily represent the views of Health Canada or any provincial or territorial government. Unless otherwise indicated, this product uses data provided by Canada’s provinces and territories. All rights reserved. The contents of this publication may be reproduced unaltered, in whole or in part and by any means, solely for non-commercial purposes, provided that the Canadian Institute for Health Information is properly and fully acknowledged as the copyright owner. Any reproduction or use of this publication or its contents for any commercial purpose requires the prior written authorization of the Canadian Institute for Health Information. Reproduction or use that suggests endorsement by, or affiliation with, the Canadian Institute for Health Information is prohibited. For permission or information, please contact CIHI: Canadian Institute for Health Information 495 Richmond Road, Suite 600 Ottawa, Ontario K2A 4H6 Phone: 613-241-7860 Fax: 613-241-8120 www.cihi.ca [email protected] © 2018 Canadian Institute for Health Information Cette publication est aussi disponible en français sous le titre Guide de codification des données en obstétrique. Table of contents About CIHI ................................................................................................................................. 6 Chapter 1: Introduction ..............................................................................................................
    [Show full text]